Escitalopram Pill

DRUG4 trials

Sponsors

Howard Aizenstein, NYU Langone Health, Peking University, Mazra Mental Health Center

Conditions

Affective DisorderAlzheimer DiseaseDepression, AnxietyMajor Depressive Disorder

Phase 1

A Proof of Concept Study of the Prevention of Mild Cognitive Impairment and Eventual Alzheimer's Disease Using F18 Flutemetamol

TerminatedNCT03274817

NYU Langone HealthAlzheimer Disease

Start: 2009-06-18End: 2019-09-25Updated: 2020-06-02

Chinese Herb for the Treatment of Depression and Anxiety Disorders

Mazra Mental Health CenterDepression, Anxiety

Start: 2017-08-28End: 2018-12-30Target: 60Updated: 2017-10-27

Phase 4

Neural Mechanisms of Monoaminergic Engagement in Late-life Depression Treatment Response (NEMO)

CompletedNCT03128021

Howard AizensteinMajor Depressive Disorder

Start: 2017-05-24End: 2023-08-30Updated: 2025-03-10

Unknown Phase

Towards Neurobiology-based Diagnosis and Treatment of Affective Disorders

Peking UniversityAffective Disorder

Start: 2016-01-31End: 2022-08-31Target: 400Updated: 2021-08-30

Related Papers

Quantitative scale validation of the Dimensional Anhedonia Rating Scale in the treatment of Chinese patients with major depressive disorder

General Psychiatry2025-04-011 citations

A distinctive subcortical functional connectivity pattern linking negative affect and treatment outcome in major depressive disorder.

2024-03-053 citations

Define and characterize the anhedonia in major depressive disorder: An explorative study.

2022-07-0315 citations

<scp>Eight‐week</scp> antidepressant treatment reduces functional connectivity in <scp>first‐episode drug‐naïve</scp> patients with major depressive disorder

Human Brain Mapping2021-02-2746 citations